A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice
Year: 2019
Type: article
Abstract: mice and found that a decrease in ACE levels promoted Aβ42 deposition and increased the number of apoptotic neurons. These results suggest that inhibition of ACE activity is a risk factor for impaired human cognition and for triggering AD onset.
Source: Journal of Biological Chemistry
Authors: Shuyu Liu, Fujiko Ando, Yu Fujita, Junjun Liu, Tomoji Maeda, Xuefeng Shen, Kota Kikuchi, Aoi Matsumoto, Mirai Yokomori, Chiaki Tanabe-Fujimura, Hiroshi Shimokata, Makoto Michikawa, Hiroto Komano, Kun Zou
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
OpenAlex ID: W2944647323
